Skip to content

In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens

Evaluation of Fit and Visual Acuity of the Cypress Toric Lens in Two Phases: Part A: A Non-Dispensing Comparison to SofLens66® Toric and Acuvue® 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00584727
Enrollment
96
Registered
2008-01-02
Start date
2007-09-30
Completion date
2007-11-30
Last updated
2015-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Keywords

astigmatism, visual acuity, fit, comfort, satisfaction, contact lens

Brief summary

The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric and a spherical contact lens currently available in market, specifically with regards to the fit and visual acuity as well as the comfort, vision and satisfaction while in the practitioner's office. Approximately 2 hours duration.

Detailed description

Non-dispensing, single-masked (subject-masked), randomised, controlled study.

Interventions

contact lens

contact lens

Sponsors

Foresight Regulatory Strategies, Inc.
CollaboratorINDUSTRY
Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed). 2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy 3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study. 4. be able and willing to adhere to the instructions set forth in the protocol. 5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study. 6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes 7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye. 8. be in good general health, based on his/her knowledge. 9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.

Exclusion criteria

1. The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer. 2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures. 3. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc). 4. Slit lamp findings that would contraindicate contact lens wear such as: * Pathological dry eye or associated findings * Pterygium or corneal scars within the visual axis * Neovascularization \>1mm in from the limbus * History of giant papillary conjunctivitis (GPC) worse than Grade 2 * Anterior uveitis or iritis (past or present) * Seborrhoeic eczema, seborrhoeic conjunctivitis 5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections. 6. A known history of corneal hypoesthesia (reduced corneal sensitivity.) 7. Aphakia, keratoconus or a highly irregular cornea. 8. Current pregnancy or lactation (to the best of the subject's knowledge). 9. Active participation in another clinical study at any time during this study.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity15-20 minutesNumber of eyes with Distance Visual Acuity 20/20 or better
Patient Reported Vision15-20 minutesA weighted combined score calculated from individual confort-vision related questions asked on a 1-5 scale, 1=most negative resonse to 5=most positive response, was used to derive vision scores. The analysis shows the difference in outcome between test and control. \>0=greater vision, \<0=lesser vision.
Lens Orientation Within 5 Degrees1 minuteMeaures in what position does the lens sit on the eye at insertion and is measured in degrees of rotation.
Lens Stability Within 5 Degrees1 minuteMeasures if the lens changes position on the eye as it is worn and is measured in degrees of rotation.
Patient Reported Comfort.15-20 minutesA weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. \>0=comfortable, \<0=uncomfortable
Patient Preferenceend of studyThis outcome measures which lens the subjects preferred to wear.

Participant flow

Participants by arm

ArmCount
Completed Population
Only participants that completed the study are included (n=88)
88
Total88

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
First InterventionDiscontinuation001000
Third InterventionProtocol Violation001042

Baseline characteristics

CharacteristicCompleted Population
Age, Continuous28.0 years
STANDARD_DEVIATION 5.96
Sex: Female, Male
Female
52 Participants
Sex: Female, Male
Male
36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —— / —
other
Total, other adverse events
0 / 170 / 170 / 160 / 140 / 160 / 16
serious
Total, serious adverse events
0 / 170 / 170 / 160 / 140 / 160 / 16

Outcome results

Primary

Lens Orientation Within 5 Degrees

Meaures in what position does the lens sit on the eye at insertion and is measured in degrees of rotation.

Time frame: 1 minute

Population: Analysis includes participants who completed the study per protocol (n=88 subjects, 176 eyes)

ArmMeasureValue (NUMBER)
Senofilcon A ToricLens Orientation Within 5 Degrees142 degrees
Alphafilcon A ToricLens Orientation Within 5 Degrees126 degrees
Comparison: Aletrnative hypothesis was senofilcon A toric was superior to alphafilcon A toric by having more eyes within 5 degrees.p-value: 0.2161Chi-squared
Primary

Lens Stability Within 5 Degrees

Measures if the lens changes position on the eye as it is worn and is measured in degrees of rotation.

Time frame: 1 minute

Population: Analysis includes participants who completed the study per protocol (n=88 subjects, 176 eyes)

ArmMeasureValue (NUMBER)
Senofilcon A ToricLens Stability Within 5 Degrees156 degrees
Alphafilcon A ToricLens Stability Within 5 Degrees140 degrees
Comparison: Alternative hypothesis was senofilcon A toric was superior to alphafilcon A toric by having more eyes within 5 degreesp-value: 0.1328Chi-squared
Primary

Patient Preference

This outcome measures which lens the subjects preferred to wear.

Time frame: end of study

Population: Analysis includes participants who completed the study per protocol (n=88)

ArmMeasureValue (NUMBER)
Senofilcon A ToricPatient Preference62 Number of participants
Alphafilcon A ToricPatient Preference5 Number of participants
Etafilcon A SpherePatient Preference18 Number of participants
Comparison: Alternative hypothesis was senofilcon A toric was superior to etafilcon A sphere.p-value: <0.0001Chi-squared
Primary

Patient Reported Comfort.

A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. \>0=comfortable, \<0=uncomfortable

Time frame: 15-20 minutes

Population: Analysis includes participants who completed the study per protocol (n=88)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon A ToricPatient Reported Comfort.0.1425 Scores on a scaleStandard Error 0.1034
Alphafilcon A ToricPatient Reported Comfort.-0.3464 Scores on a scaleStandard Error 0.1035
Etafilcon A SpherePatient Reported Comfort.0.2176 Scores on a scaleStandard Error 0.1028
Comparison: Alternative hypothesis was senofilcon A toric was superior to alphafilcon A toric.95% CI: [0.1529, 0.489]Mixed Models Analysis
Primary

Patient Reported Vision

A weighted combined score calculated from individual confort-vision related questions asked on a 1-5 scale, 1=most negative resonse to 5=most positive response, was used to derive vision scores. The analysis shows the difference in outcome between test and control. \>0=greater vision, \<0=lesser vision.

Time frame: 15-20 minutes

Population: Analysis includes participants who completed the study per protocol (n=88)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon A ToricPatient Reported Vision0.2845 Scores on a scaleStandard Error 0.098
Alphafilcon A ToricPatient Reported Vision0.1332 Scores on a scaleStandard Error 0.098
Etafilcon A SpherePatient Reported Vision-0.4310 Scores on a scaleStandard Error 0.097
Comparison: Alternative hypothesis was senofilcon A toric was superior to etafilcon A sphere.95% CI: [0.3625, 0.7155]Mixed Models Analysis
Primary

Visual Acuity

Number of eyes with Distance Visual Acuity 20/20 or better

Time frame: 15-20 minutes

Population: Analysis includes participants who completed the study per protocol (n=88 subjects,176 eyes)

ArmMeasureValue (NUMBER)
Senofilcon A ToricVisual Acuity146 Eyes with Snellen VA 20/20 or better
Alphafilcon A ToricVisual Acuity136 Eyes with Snellen VA 20/20 or better
Etafilcon A SphereVisual Acuity37 Eyes with Snellen VA 20/20 or better
Comparison: Alternative hypothesis was senofilcon A toric was superior to etafilcon A sphere by having more eyes see 20/20p-value: <0.0001Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026